Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion type Assertion NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_head.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion description "[We have previously shown that glucose-dependent insulinotropic polypeptide (GIP) analogues that originally have been developed to treat diabetes have neuroprotective effects in the brains of the APPswe/PS1?E9 mouse model of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_provenance.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion evidence source_evidence_literature NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_provenance.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion SIO_000772 23568101 NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_provenance.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion wasDerivedFrom befree-20150227 NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_provenance.
- NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_assertion wasGeneratedBy ECO_0000203 NP425278.RASaHgr0e0PKpcwTLD_n458wj6fJFmW7TimHGo6nJ_bEw130_provenance.